(Q40907007)

24 September 2017

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma (English)

1 reference

24 September 2017

6

Bostwick DG

1 reference

24 September 2017

Pisansky TM

1

1 reference

24 September 2017

Kahn MJ

2

1 reference

24 September 2017

Rasp GM

3

1 reference

24 September 2017

Cha SS

4

1 reference

24 September 2017

Haddock MG

5

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 January 1997

1 reference

24 September 2017

1 reference

24 September 2017

79

1 reference

24 September 2017

337-344

1 reference

24 September 2017

2

1 reference

Prostate cancer. Radiation therapy for localized disease

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Long-term survival among men with conservatively treated localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Correlation of pretherapy prostate cancer characteristics with histologic findings from pelvic lymphadenectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Correlation of pretherapy prostate cancer characteristics with seminal vesicle invasion in radical prostatectomy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Prognostic grouping: the next step in tumor classification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Recent results of management of palpable clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Patient Outcomes Research Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Definitive therapy for prostate carcinoma: Mayo Clinic results at 15 years after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Prostate-specific antigen and radiation therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Prostate-specific antigen as a pretherapy prognostic factor in patients treated with radiation therapy for clinically localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Measurement of serum prostate specific antigen using IMx prostate specific antigen assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819970115%2979%3A2%3C337%3A%3AAID-CNCR17%3E3.0.CO%3B2-1

10.1002/(SICI)1097-0142(19970115)79:2<337::AID-CNCR17>3.0.CO;2-1

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference